BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6396836)

  • 21. Beta-lactam antibiotics in lower respiratory tract infections.
    Schreiner A
    Scand J Infect Dis Suppl; 1984; 42():129-34. PubMed ID: 6597558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging drugs for bacterial urinary tract infections.
    Wagenlehner FM; Weidner W; Naber KG
    Expert Opin Emerg Drugs; 2005 May; 10(2):275-98. PubMed ID: 15934867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction: historical perspective and development of amoxicillin/clavulanate.
    Geddes AM; Klugman KP; Rolinson GN
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S109-12. PubMed ID: 17900874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in the development of beta-lactam antibiotics.
    Neu HC
    Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Third-generation beta-lactam antibiotics for treatment of orthopedic infections.
    Mogabgab WJ; Haddad RJ; Longenecker SL; Buchanan TC; Johnston R; Macey TI; Bernard T; Floyd I
    Clin Ther; 1982; 5(1):21-43. PubMed ID: 7127366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
    Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance and administration of beta-lactam antibiotics in practice].
    Kienitz M
    Med Welt; 1982 Aug; 33(31-32):1102-4. PubMed ID: 7132655
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of antibiotics in hospitalized patients. Comparison of medical, surgical and gynecological units].
    Kewitz G; Salfinger M; Farina JC; Dickreuter W; Berger D; Galliker H; Krupp P; Follath F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):10-4. PubMed ID: 7209474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
    Dolapçi I
    Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary tract infections--still a real problem].
    Cermák P; Veselský Z
    Cas Lek Cesk; 2000 Jul; 139(14):426-31. PubMed ID: 11048404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of bacterial urinary tract infections: presence and future.
    Wagenlehner FM; Naber KG
    Eur Urol; 2006 Feb; 49(2):235-44. PubMed ID: 16413668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pivmecillinam in the treatment of urinary tract infections.
    Nicolle LE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of bacterial infections with the newer antibiotics].
    Schley G; Wenzel H
    Med Klin; 1981 Mar; 76(7):200-7. PubMed ID: 6971983
    [No Abstract]   [Full Text] [Related]  

  • 40. The menace of beta-lactamase production on antibiotic prescription in community acquired-infections in Nigeria.
    Oyelese AO; Oyewo EA
    Afr J Med Med Sci; 1995 Jun; 24(2):125-30. PubMed ID: 8669389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.